SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'IM2'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GHM_A_CEDA1_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222LYS A 225SER A 281ASN A 283LYS A 424GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.4A) | 0.48A | 1ghmA-3upnA:16.7 | 1ghmA-3upnA:21.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GHM_A_CEDA1_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64LYS A 67SER A 125ASN A 127LYS A 229GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.29A | 1ghmA-5f83A:35.6 | 1ghmA-5f83A:28.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1I2W_A_CFXA1300_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222LYS A 225SER A 281ASN A 283LYS A 424GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.4A) | 0.42A | 1i2wA-3upnA:17.2 | 1i2wA-3upnA:21.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_A_CFXA1300_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 8 / 12 | SER A 64LYS A 67SER A 125ASN A 127GLU A 161THR A 211LYS A 229GLY A 231 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-2.5A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A) | 0.33A | 1i2wA-5f83A:37.7 | 1i2wA-5f83A:35.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1I2W_B_CFXB2300_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 8 / 12 | SER A 64LYS A 67SER A 125ASN A 127GLU A 161THR A 211GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-2.5A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.32A | 1i2wB-5f83A:37.8 | 1i2wB-5f83A:35.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK9_B_2FAB307_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 9 | MET A 164GLY A 128GLU A 163SER A 100ASP A 126 | IM2 A 301 ( 4.6A)NoneNoneNoneNone | 1.49A | 1pk9B-5f83A:undetectable | 1pk9B-5f83A:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PW7_A_RABA645_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 10 | MET A 164GLY A 128GLU A 163SER A 100ASP A 126 | IM2 A 301 ( 4.6A)NoneNoneNoneNone | 1.49A | 1pw7A-5f83A:undetectable | 1pw7A-5f83A:23.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YMX_A_CFXA1001_1 (BETA-LACTAMASECTX-M-9) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222LYS A 225SER A 281ASN A 283LYS A 424GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.4A) | 0.58A | 1ymxA-3upnA:18.0 | 1ymxA-3upnA:23.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_A_CFXA1001_1 (BETA-LACTAMASECTX-M-9) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 8 / 12 | SER A 64LYS A 67SER A 125ASN A 127GLU A 161THR A 211LYS A 229GLY A 231 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-2.5A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A) | 0.59A | 1ymxA-5f83A:39.6 | 1ymxA-5f83A:37.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_A_CFXA1001_1 (BETA-LACTAMASECTX-M-9) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 8 / 12 | SER A 64LYS A 67SER A 125ASN A 127THR A 211LYS A 229GLY A 231ASP A 166 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A)None | 1.16A | 1ymxA-5f83A:39.6 | 1ymxA-5f83A:37.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YMX_B_CFXB1002_1 (BETA-LACTAMASECTX-M-9) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222LYS A 225SER A 281ASN A 283LYS A 424GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.4A) | 0.52A | 1ymxB-3upnA:18.2 | 1ymxB-3upnA:23.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_B_CFXB1002_1 (BETA-LACTAMASECTX-M-9) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64LYS A 67SER A 125ASN A 127GLU A 161LYS A 229GLY A 231 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-2.5A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A) | 0.57A | 1ymxB-5f83A:39.4 | 1ymxB-5f83A:37.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_B_CFXB1002_1 (BETA-LACTAMASECTX-M-9) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | SER A 64LYS A 67SER A 125ASN A 127LYS A 229ASP A 166 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)None | 0.80A | 1ymxB-5f83A:39.4 | 1ymxB-5f83A:37.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YMX_B_CFXB1002_2 (BETA-LACTAMASECTX-M-9) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 4 / 5 | CYH A 233PRO A 260THR A 215THR A 230 | NoneNoneNoneIM2 A 301 (-3.6A) | 1.42A | 1ymxB-5f83A:39.4 | 1ymxB-5f83A:37.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HLW_A_CE3A301_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 5 / 12 | LYS A 225SER A 281ASN A 283LYS A 424GLY A 426 | IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.4A) | 0.55A | 3hlwA-3upnA:18.1 | 3hlwA-3upnA:23.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_A_CE3A301_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | LYS A 67SER A 125ASN A 127THR A 211LYS A 229GLY A 231 | IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A) | 0.29A | 3hlwA-5f83A:39.3 | 3hlwA-5f83A:37.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HLW_B_CE3B302_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | SER A 125ASN A 127THR A 211LYS A 229THR A 230GLY A 231 | IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A) | 0.23A | 3hlwB-5f83A:39.3 | 3hlwB-5f83A:37.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HUO_A_PNNA300_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 5 / 12 | LYS A 225ASN A 283LYS A 424THR A 425GLY A 426 | IM2 A 800 ( 4.5A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.58A | 3huoA-3upnA:18.1 | 3huoA-3upnA:23.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HUO_A_PNNA300_0 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 12 | LYS A 67ASN A 127LYS A 229THR A 230GLY A 231 | IM2 A 301 ( 3.9A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A) | 0.19A | 3huoA-5f83A:39.4 | 3huoA-5f83A:37.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LS4_H_TCIH220_1 (HEAVY CHAIN OFANTIBODY FABFRAGMENT) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 5 / 10 | VAL A 342LEU A 344GLY A 338GLY A 221TRP A 442 | NoneNoneNoneIM2 A 800 (-4.0A)None | 1.12A | 3ls4H-3upnA:undetectable | 3ls4H-3upnA:19.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINECARBOXYPEPTIDASEDACA) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222LYS A 225GLY A 262ASN A 283THR A 425GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 ( 4.5A)NoneIM2 A 800 (-3.3A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.82A | 3mzeA-3upnA:6.0 | 3mzeA-3upnA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MZE_A_CFXA364_1 (D-ALANYL-D-ALANINECARBOXYPEPTIDASEDACA) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | SER A 64LYS A 67ASN A 127THR A 230GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-3.2A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.93A | 3mzeA-5f83A:22.4 | 3mzeA-5f83A:24.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NY4_A_SMXA308_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.50A | 3ny4A-5f83A:37.8 | 3ny4A-5f83A:37.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NY4_A_SMXA308_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | THR A 211LYS A 229THR A 230GLY A 231THR A 232GLY A 237 | IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A)None | 1.31A | 3ny4A-5f83A:37.8 | 3ny4A-5f83A:37.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 5 / 12 | LYS A 225SER A 281ASN A 283LYS A 424GLY A 426 | IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.4A) | 0.46A | 3q07A-3upnA:18.1 | 3q07A-3upnA:23.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | LYS A 67SER A 125ASN A 127LYS A 229GLY A 231ASP A 166 | IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A)None | 1.12A | 3q07A-5f83A:39.4 | 3q07A-5f83A:37.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 5 / 12 | LYS A 225SER A 281ASN A 283LYS A 424GLY A 426 | IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.4A) | 0.65A | 3q07B-3upnA:18.1 | 3q07B-3upnA:23.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | LYS A 67SER A 125ASN A 127LYS A 229GLY A 231ASP A 166 | IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A)None | 1.13A | 3q07B-5f83A:37.0 | 3q07B-5f83A:37.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SH8_A_CEDA1_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281ASN A 283LYS A 424THR A 425GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.54A | 3sh8A-3upnA:17.6 | 3sh8A-3upnA:21.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_A_CEDA1_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125ASN A 127LYS A 229THR A 230GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.28A | 3sh8A-5f83A:36.7 | 3sh8A-5f83A:34.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SH8_B_CEDB1_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222LYS A 225SER A 281ASN A 283LYS A 424GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.4A) | 0.50A | 3sh8B-3upnA:17.6 | 3sh8B-3upnA:21.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SH8_B_CEDB1_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64LYS A 67SER A 125ASN A 127LYS A 229GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.32A | 3sh8B-5f83A:36.1 | 3sh8B-5f83A:34.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DA6_A_GA2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 9 | MET A 164GLY A 128GLU A 163SER A 100ASP A 126 | IM2 A 301 ( 4.6A)NoneNoneNoneNone | 1.49A | 4da6A-5f83A:undetectable | 4da6A-5f83A:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | LYS A 225SER A 281ASN A 283LYS A 424THR A 425GLY A 426 | IM2 A 800 ( 4.5A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.69A | 4euzA-3upnA:17.5 | 4euzA-3upnA:23.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 8 / 12 | LYS A 67SER A 125ASN A 127THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.44A | 4euzA-5f83A:39.4 | 4euzA-5f83A:40.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 5 / 10 | SER A 281ASN A 283LYS A 424THR A 425GLY A 426 | IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.54A | 4fh2A-3upnA:17.9 | 4fh2A-3upnA:23.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 10 | SER A 125ASN A 127LYS A 229THR A 230GLY A 231ARG A 238 | IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.48A | 4fh2A-5f83A:37.5 | 4fh2A-5f83A:36.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MM5_A_SREA603_1 (TRANSPORTER) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 9 | PRO A 69ALA A 71GLY A 63PHE A 66SER A 125 | NoneNoneIM2 A 301 ( 3.9A)NoneIM2 A 301 (-2.7A) | 1.32A | 4mm5A-5f83A:undetectable | 4mm5A-5f83A:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MMB_A_SREA603_1 (TRANSPORTER) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 9 | PRO A 69ALA A 71GLY A 63PHE A 66SER A 125 | NoneNoneIM2 A 301 ( 3.9A)NoneIM2 A 301 (-2.7A) | 1.29A | 4mmbA-5f83A:0.4 | 4mmbA-5f83A:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N9K_A_CEDA301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281ASN A 283LYS A 424THR A 425GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.51A | 4n9kA-3upnA:17.6 | 4n9kA-3upnA:22.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_A_CEDA301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125ASN A 127LYS A 229THR A 230GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.24A | 4n9kA-5f83A:38.4 | 4n9kA-5f83A:34.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N9K_B_CEDB301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281ASN A 283LYS A 424THR A 425GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.55A | 4n9kB-3upnA:17.5 | 4n9kB-3upnA:22.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9K_B_CEDB301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125ASN A 127LYS A 229THR A 230GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.26A | 4n9kB-5f83A:38.3 | 4n9kB-5f83A:34.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM5_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 12 | ASN A 127THR A 211LYS A 229THR A 230GLY A 231 | IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A) | 0.21A | 4pm5A-5f83A:39.4 | 4pm5A-5f83A:37.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM7_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 12 | LYS A 67ASN A 127THR A 211LYS A 229GLY A 231 | IM2 A 301 ( 3.9A)IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A) | 0.30A | 4pm7A-5f83A:39.4 | 4pm7A-5f83A:37.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM7_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 12 | LYS A 67SER A 125ASN A 127LYS A 229GLY A 231 | IM2 A 301 ( 3.9A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A) | 0.74A | 4pm7A-5f83A:39.4 | 4pm7A-5f83A:37.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PM9_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 12 | ASN A 127THR A 211LYS A 229THR A 230GLY A 231 | IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A) | 0.22A | 4pm9A-5f83A:39.5 | 4pm9A-5f83A:38.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_A_CEDA301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | SER A 64SER A 125ASN A 127LYS A 229GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.29A | 5ghyA-5f83A:37.9 | 5ghyA-5f83A:34.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHY_B_CEDB301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | SER A 64SER A 125ASN A 127LYS A 229GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.27A | 5ghyB-5f83A:38.0 | 5ghyB-5f83A:34.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHZ_A_CEDA301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 11 | SER A 222SER A 281ASN A 283LYS A 424THR A 425GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.53A | 5ghzA-3upnA:17.4 | 5ghzA-3upnA:21.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_A_CEDA301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 11 | SER A 64SER A 125ASN A 127LYS A 229THR A 230GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.26A | 5ghzA-5f83A:38.0 | 5ghzA-5f83A:34.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GHZ_B_CEDB301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 10 | SER A 222SER A 281ASN A 283LYS A 424THR A 425GLY A 426 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A) | 0.54A | 5ghzB-3upnA:17.4 | 5ghzB-3upnA:21.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GHZ_B_CEDB301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 10 | SER A 64SER A 125ASN A 127LYS A 229THR A 230GLY A 231ARG A 238 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-3.5A) | 0.27A | 5ghzB-5f83A:38.0 | 5ghzB-5f83A:34.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NZ0_A_ZLDA301_0 (HTH-TYPETRANSCRIPTIONALREGULATOR ETHR) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 5 / 12 | GLY A 338ILE A 337THR A 427ASN A 283LEU A 258 | NoneNoneIM2 A 800 (-4.0A)IM2 A 800 (-3.3A)None | 1.41A | 5nz0A-3upnA:undetectable | 5nz0A-3upnA:19.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OJ0_A_9WTA801_0 (PENICILLIN-BINDINGPROTEIN 2X) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 5 / 12 | SER A 281ASN A 283GLN A 339GLY A 426THR A 427 | IM2 A 800 (-3.0A)IM2 A 800 (-3.3A)NoneIM2 A 800 (-3.4A)IM2 A 800 (-4.0A) | 0.94A | 5oj0A-3upnA:31.3 | 5oj0A-3upnA:22.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OJ0_A_9WTA801_0 (PENICILLIN-BINDINGPROTEIN 2X) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 12 | TRP A 99SER A 125THR A 211GLY A 231THR A 232 | IM2 A 301 ( 4.0A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 1.23A | 5oj0A-5f83A:6.9 | 5oj0A-5f83A:18.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WM2_A_ACTA605_0 (SALICYLATE-AMPLIGASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 3 / 3 | THR A 211THR A 230ARG A 238 | IM2 A 301 (-4.1A)IM2 A 301 (-3.6A)IM2 A 301 (-3.5A) | 1.00A | 5wm2A-5f83A:undetectable | 5wm2A-5f83A:20.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281LYS A 424THR A 425GLY A 426THR A 427 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A)IM2 A 800 (-4.0A) | 0.94A | 6b5yB-3upnA:8.0 | 6b5yB-3upnA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.39A | 6b5yB-5f83A:38.3 | 6b5yB-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.46A | 6b5yD-5f83A:38.2 | 6b5yD-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | THR A 211LYS A 229THR A 230GLY A 231THR A 232GLY A 237 | IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A)None | 1.33A | 6b5yD-5f83A:38.2 | 6b5yD-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281LYS A 424THR A 425GLY A 426THR A 427 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A)IM2 A 800 (-4.0A) | 0.89A | 6b68B-3upnA:17.4 | 6b68B-3upnA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.33A | 6b68B-5f83A:38.5 | 6b68B-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | THR A 211LYS A 229THR A 230GLY A 231THR A 232GLY A 237 | IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A)None | 1.40A | 6b68B-5f83A:38.5 | 6b68B-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_D_9F2D400_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | SER A 64SER A 125THR A 211LYS A 229GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.40A | 6b68D-5f83A:38.3 | 6b68D-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281LYS A 424THR A 425GLY A 426THR A 427 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A)IM2 A 800 (-4.0A) | 0.88A | 6b69A-3upnA:17.36b69B-3upnA:17.1 | 6b69A-3upnA:14.126b69B-3upnA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 8 / 12 | SER A 64SER A 125PRO A 162THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)NoneIM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.47A | 6b69A-5f83A:38.46b69B-5f83A:38.4 | 6b69A-5f83A:15.996b69B-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | THR A 211LYS A 229THR A 230GLY A 231THR A 232GLY A 237 | IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A)None | 1.40A | 6b69A-5f83A:38.46b69B-5f83A:38.4 | 6b69A-5f83A:15.996b69B-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_D_9F2D301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281LYS A 424THR A 425GLY A 426THR A 427 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A)IM2 A 800 (-4.0A) | 0.87A | 6b69D-3upnA:8.0 | 6b69D-3upnA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_D_9F2D301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.33A | 6b69D-5f83A:38.3 | 6b69D-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_B_9F2B301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.37A | 6b6aB-5f83A:38.4 | 6b6aB-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_D_9F2D301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281LYS A 424THR A 425GLY A 426THR A 427 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A)IM2 A 800 (-4.0A) | 0.88A | 6b6aD-3upnA:16.5 | 6b6aD-3upnA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_D_9F2D301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | SER A 64SER A 125LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.28A | 6b6aD-5f83A:38.3 | 6b6aD-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6C_A_9F2A301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125PRO A 162LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)NoneIM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.63A | 6b6cA-5f83A:38.3 | 6b6cA-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6D_A_9F2A302_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.59A | 6b6dA-5f83A:38.0 | 6b6dA-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6E_A_9F2A302_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281LYS A 424THR A 425GLY A 426THR A 427 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A)IM2 A 800 (-4.0A) | 0.89A | 6b6eA-3upnA:17.3 | 6b6eA-3upnA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6E_A_9F2A302_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125THR A 211LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.34A | 6b6eA-5f83A:38.2 | 6b6eA-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6E_A_9F2A302_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 6 / 12 | THR A 211LYS A 229THR A 230GLY A 231THR A 232GLY A 237 | IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A)None | 1.39A | 6b6eA-5f83A:38.2 | 6b6eA-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
3upn | PENICILLIN-BINDINGPROTEIN A (Mycobacteriumtuberculosis) | 6 / 12 | SER A 222SER A 281LYS A 424THR A 425GLY A 426THR A 427 | IM2 A 800 (-1.3A)IM2 A 800 (-3.0A)IM2 A 800 ( 3.9A)IM2 A 800 (-3.5A)IM2 A 800 (-3.4A)IM2 A 800 (-4.0A) | 1.01A | 6b6fA-3upnA:17.3 | 6b6fA-3upnA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 7 / 12 | SER A 64SER A 125PRO A 162LYS A 229THR A 230GLY A 231THR A 232 | IM2 A 301 (-1.4A)IM2 A 301 (-2.7A)NoneIM2 A 301 (-3.3A)IM2 A 301 (-3.6A)IM2 A 301 (-3.3A)IM2 A 301 (-4.0A) | 0.72A | 6b6fA-5f83A:37.9 | 6b6fA-5f83A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C79_A_CE3A301_1 (BETA-LACTAMASETOHO-1) |
5f83 | BETA-LACTAMASE (Pseudomonasaeruginosa) | 5 / 12 | SER A 125ASN A 127THR A 211LYS A 229GLY A 231 | IM2 A 301 (-2.7A)IM2 A 301 (-3.2A)IM2 A 301 (-4.1A)IM2 A 301 (-3.3A)IM2 A 301 (-3.3A) | 0.13A | 6c79A-5f83A:39.0 | 6c79A-5f83A:14.79 |